Company: THC
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0000070318-25-000039
Chunk: 94

Company: TENET HEALTHCARE CORP
Filing Date: 2025-07-30
Form: 10-Q
Item: Part I, Item 2
Chunk 94
---
30, 2025, respectively, and $5 million and $9 million for the same periods in 2024, respectively.

Net Losses (Gains) on Sales, Consolidation and Deconsolidation of Facilities

We recorded net losses from the sale, consolidation and deconsolidation of facilities totaling $38 million and $16 million during the three and six months ended June 30, 2025, respectively. During the three months ended June 30, 2025, we recorded net losses of $42 million associated with the consolidation of certain facilities, partially offset by net gains of $4 million from the sale of facilities, all within our Ambulatory Care segment. During the six-month period, we recorded net losses of $33 million related to the consolidation of certain facilities by our Ambulatory Care segment, partially offset by a gain of $10 million related to post-closing adjustments from the divestiture of the AL Hospitals by our Hospital Operations segment, net gains of $4 million from the sale of facilities by our Ambulatory Care segment and a gain of $3 million related to other activity.

We recorded gains from the sale, consolidation and deconsolidation of facilities totaling $58 million and $2.558 billion during the three and six months ended June 30, 2024, respectively. In the three months ended June 30, 2024, we recorded a gain of $36 million from the consolidation of certain facilities in which we previously owned a noncontrolling interest and a gain of $20 million from the sale of an ASC, all related to our Ambulatory Care segment. During the six months ended June 30, 2024, we also recognized a gain of $1.677 billion related to our sale of the SC Hospitals, a gain of $526 million from the sale of the OCLA CA Hospitals, a gain of $275 million from our sale of the Central CA Hospitals and a gain of $23 million from the sale of two ASCs by our Ambulatory Care segment.

39

Interest Expense

Interest expense for the three and six months ended June 30, 2025 was $206 million and $410 million, respectively, compared to $203 million and $421 million, respectively, for the same periods in 2024.

Loss from Early Extinguishment of Debt

We did not incur any losses related to the early extinguishment